Aspen RxHealth Adds Targeted Medication Review and Health Plan Star Rating Services to its Clinical Documentation Tool for Pharmacists
Aspen RxHealth announced today a new major release of its intelligent app that connects pharmacists with patients to support optimal medication use. The app makes it easy for health plans and providers to connect their patients with an on-demand community of pharmacists. A first-of-its-kind clinical documentation tool for pharmacists, Aspen RxHealth now offers targeted medication reviews (TMR) that drive health plan Star Ratings.
“Our intelligent app opens up an entirely new ‘gig economy’ for pharmacists and makes it easy for health plans to leverage the skills of thousands of pharmacist experts who are available at any given time,” said Dr. David Medvedeff, chief executive officer, Aspen RxHealth. “We bridge the gap between pharmacists who want an opportunity to practice at the top of their license and patients who need medication management services. In doing so, we enable a more engaged, holistic relationship between pharmacist and patient.”
New Services in Version 2.0
A recent Humana study comparing the differences in medication therapy management (MTM) services found that targeted medication reviews (TMR) were highly successful interventions. The study highlights how critical it is for Part D and Medicare Advantage plans to contribute to better therapeutic outcomes for the patients they serve. Furthermore, the study determined that TMR interventions were more successful at lowering acute inpatient admissions. Patients were far more likely to adhere to their medications when their providers focused on targeted interventions and were less likely to visit the emergency department.
Medicare uses a Star Rating System to measure how well Medicare Advantage and Part D plans perform. Medicare scores performance in several categories, including quality of care and customer service. The Aspen RxHealth platform supports pharmacy-related Star Measures including medication adherence and the use of cholesterol-lowering medications known as “statins” in patients with diabetes.